William Bertrand Net Worth & Insider Trades

William Bertrand - Chief Operating Officer, Adaptimmune Therapeutics Plc

As of December 15, 2020

What is William Bertrand's Net Worth?

The current estimated net worth of Adaptimmune Therapeutics Plc's Chief Operating Officer, William Bertrand, is estimated to be about $176.16K . William Bertrand owns about 284,808 units of Adaptimmune Therapeutics Plc common stock. Recently at Adaptimmune Therapeutics Plc, William Bertrand has sold an estimated value of $0 worth.

What is William Bertrand's Past Insider Trading?

William Bertrand's largest purchase order was 207,000 units , worth over $143.82K on December 15, 2020. In total, William Bertrand has made about 1 transaction recently at Adaptimmune Therapeutics Plc. William Bertrand usually trades in December, with the busiest year in 2020.

William Charles Bertrand

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was William Bertrand's Salary in 2020?

As Chief Operating Officer of Adaptimmune Therapeutics Plc, William Bertrand has a total base salary of $443,456 . William Bertrand received compensation valued at about $1,551,113 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of option awards of $857,661 , other earnings, plans or compensations of $219,511 , and other compensation of $30,485 .

What is William Bertrand's' Mailing Address?

  • Mailing address is One Medimmune Way Gaithersburg MD 20878 MD

Adaptimmune Therapeutics Plc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Adrian Rawcliffe 2020 $574,000 $1,715,346 $378,840 $33,416 $2,701,602
Adrian Rawcliffe 2019 $500,481 $1,427,399 $177,251 $49,912 $2,155,042
Adrian Rawcliffe 2018 $457,011 $730,791 $174,807 $54,775 $1,417,384
Gavin Wood 2020 $337,065 $990,268 $166,847 $73,731 $1,567,911
Helen Tayton-Martin 2020 $454,940 $857,661 $225,195 $23,531 $1,561,327
Helen Tayton-Martin 2019 $435,949 $766,900 $137,324 $30,491 $1,370,664
Helen Tayton-Martin 2018 $408,308 $730,791 $156,178 $22,007 $1,317,284
William Bertrand 2020 $443,456 $857,661 $219,511 $30,485 $1,551,113
William Bertrand 2019 $432,640 $766,900 $136,282 $35,358 $1,371,180
William Bertrand 2018 $416,000 $685,114 $159,120 $35,070 $1,295,304
John Lunger 2020 $400,000 $857,661 $198,000 $31,802 $1,487,463
John Lunger 2019 $366,867 $435,546 $94,542 $35,655 $932,610
John Lunger 2018 $316,958 $602,909 $92,948 $35,07 $1,047,885
Michael Garone 2020 $217,000 - - - $217,000
Michael Garone 2019 $206,500 - - - $206,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1621227/000110465921047833/tm212433-2_def14a.htm

What are Adaptimmune Therapeutics Plc's Past Insider Trades?

Adaptimmune Therapeutics Plc's most recent insider trade came on September 1, 2022 by Adrian Rawcliffe who sold 2,536 units worth $4.99K . In the last 6 years, insiders at Adaptimmune Therapeutics Plc have sold an estimated value of $40.15M and bought an estimated value of $526.78M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Adrian Rawcliffe, Chief Executive Officer,  John Lunger, Chief Patient Supply Officer,  and William Charles Bertrand, Chief Operating Officer .

Adaptimmune Therapeutics PLC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1